Search details
1.
Expanding the Spectrum of NR4A3 Fusion-Positive Gynecologic Leiomyosarcomas.
Mod Pathol
; 37(5): 100474, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38508521
2.
FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Histopathology
; 84(4): 589-600, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38010295
3.
ALK-rearranged Mesenchymal Neoplasms: A Report of 9 cases Further Expanding the Clinicopathologic Spectrum of Emerging Kinase Fusion Positive Group of Tumors.
Genes Chromosomes Cancer
; 62(2): 75-84, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36125853
4.
Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
Genes Chromosomes Cancer
; 62(4): 191-201, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36344258
5.
EWSR1::YY1 fusion positive peritoneal epithelioid mesothelioma harbors mesothelioma epigenetic signature: Report of 3 cases in support of an emerging entity.
Genes Chromosomes Cancer
; 61(10): 592-602, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35665561
6.
Androgen receptor splice variant-7 in breast cancer: clinical and pathologic correlations.
Mod Pathol
; 35(3): 396-402, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34593966
7.
NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
Mod Pathol
; 33(1): 38-46, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31375766
8.
Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion.
Mod Pathol
; 33(8): 1492-1504, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32157177
9.
Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
Mod Pathol
; 32(5): 609-620, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30459475
10.
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain Tumors.
Mol Cancer Res
; 22(1): 21-28, 2024 Jan 02.
Article
in English
| MEDLINE | ID: mdl-37870438
11.
Alzheimer's-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition.
Proc Natl Acad Sci U S A
; 107(4): 1630-5, 2010 Jan 26.
Article
in English
| MEDLINE | ID: mdl-20080541
12.
Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas.
Brain Pathol
; 33(5): e13185, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37399073
13.
Clinical Utility and Performance of an Ultrarapid Multiplex RNA-Based Assay for Detection of ALK, ROS1, RET, and NTRK1/2/3 Rearrangements and MET Exon 14 Skipping Alterations.
J Mol Diagn
; 24(6): 642-654, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35430374
14.
A Performance Comparison of Commonly Used Assays to Detect RET Fusions.
Clin Cancer Res
; 27(5): 1316-1328, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33272981
15.
A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing.
J Mol Diagn
; 23(2): 253-263, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33285287
16.
Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
Am J Pathol
; 173(2): 370-84, 2008 Aug.
Article
in English
| MEDLINE | ID: mdl-18535180
17.
Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
Am J Surg Pathol
; 43(5): 662-669, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30789359
18.
High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden.
Clin Cancer Res
; 25(15): 4712-4722, 2019 Aug 01.
Article
in English
| MEDLINE | ID: mdl-31028088
19.
Colorectal Carcinomas Containing Hypermethylated MLH1 Promoter and Wild-Type BRAF/KRAS Are Enriched for Targetable Kinase Fusions.
Cancer Res
; 79(6): 1047-1053, 2019 03 15.
Article
in English
| MEDLINE | ID: mdl-30643016
20.
Oncogenic TRK fusions are amenable to inhibition in hematologic malignancies.
J Clin Invest
; 128(9): 3819-3825, 2018 08 31.
Article
in English
| MEDLINE | ID: mdl-29920189